23andMe Personal Genome Service (PGS) Pharmacogenetic Reports— 510(k) K221885

Substantially Equivalent

23AndMe, Inc.

FDA 510(k) clearance K221885 for 23andMe Personal Genome Service (PGS) Pharmacogenetic Reports, Substantially Equivalent on 2022-10-26. Applicant: 23AndMe, Inc..

Clearance details

Applicant: 23AndMe, Inc.
Product code: Code QDJ
Advisory panel: Medical Genetics
Date received: 2022-06-29
Decision date: 2022-10-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Franciso, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.